Meeting
2022 ASCO Annual Meeting
Differential expression of somatostatin receptor (SSTR) subtypes across a spectrum of neuroendocrine neoplasms (NENs).
Authors
Emil Lou
Masonic Cancer Center/ University of Minnesota School of Medicine, Minneapolis, MN
Emil Lou , Nishant Gandhi , Alex Farrell , Joanne Xiu , Andreas Seeber , Shaalan Shaalan Beg , Minnu Monu , Sourat Darabi , Michael J. Demeure , Jim Abraham , Matthew James Oberley , John Marshall , Heloisa P. Soares
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3071)
DOI
10.1200/JCO.2022.40.16_suppl.3071
Abstract #
3071
Poster Bd #
63
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular correlates of Delta-like-ligand 3 (DLL3) expression in neuroendocrine neoplasms (NENs).
First Author: Justin Hwang
Poster
2015 Gastrointestinal Cancers Symposium
Molecular profiling of neuroendocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience.
First Author: Namrata Vijayvergia
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.
First Author: Alexandra Androsova
First Author: Albert Grinshpun